<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR814.html">Part 814
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 814.1  Scope.
                            </h3>
                            <p class="depth1"><em>(a)</em> This section implements sections 515 and 515A of the act by  providing procedures for the premarket approval of medical devices  intended for human use.</p><p class="depth1"><em>(b)</em> References in this part to regulatory sections of the Code of  Federal Regulations are to chapter I of title 21, unless otherwise  noted.</p><p class="depth1"><em>(c)</em> This part applies to any class III medical device, unless exempt  under section 520(g) of the act, that:</p><p class="depth2"><em>(1)</em> Was not on the market (introduced or delivered for introduction  into commerce for commercial distribution) before May 28, 1976, and is  not substantially equivalent to a device on the market before May 28,  1976, or to a device first marketed on, or after that date, which has  been classified into class I or class II; or</p><p class="depth2"><em>(2)</em> Is required to have an approved premarket approval application  (PMA) or a declared completed product development protocol under a  regulation issued under section 515(b) of the act; or</p><p class="depth2"><em>(3)</em> Was regulated by FDA as a new drug or antibiotic drug before May  28, 1976, and therefore is governed by section 520(1) of the act.</p><p class="depth1"><em>(d)</em> This part amends the conditions to approval for any PMA approved  before the effective date of this part. Any condition to approval for an  approved PMA that is inconsistent with this part is revoked. Any  condition to approval for an approved PMA that is consistent with this  part remains in effect.  [51 FR 26364, July 22, 1986, as amended at 79 FR 1740, Jan. 10, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
